Pfizer’s COVID pill will cut the risk of hospital admission and virus deaths. The science editor of the Times, Tom Whipple published a review of this. He suggests that the new antiviral pill will slash the risk of hospital admission and death...
An interesting article published by Cromer and others in The Lancet, November 15 discusses this issue. Several SARS-CoV-2 variants of concern have been identified which partly escape serum neutralisation elicited by the current...
The Shingrix vaccine, shingles vaccine appears to give benefit and help to reduce the risk of COVID-19 in older adults. An interesting preprint published in medRxiv by Bruxvoort and others suggests that vaccines may elicit long term boosting of innate immune responses...
A personal view published by Milne and others in The Lancet Respiratory Medicine October 21st 2021, looks at this. It is further discussed by Altmann and others in a comment published October 21st 2021. Many nations are pursuing the rollout of SARS-CoV-2...
An interesting correspondence in The Lancet rheumatology published by Sciascia October 20th 2021 discusses this issue. Vaccines represent a cornerstone in controlling the COVID-19 pandemic. The availability of data on the immunogenicity and...
An interesting letter published in the New England Journal of Medicine by Courtney Temple and others October 20th 2021 highlights this issue. Ivermectin is approved by the FDA as an oral treatment for intestinal strongyloidiasis and onchocerciasis and is a...
